A psychiatric-mental health nurse practitioner recently began prescribing controlled substances that are part of a medication-assisted treatment (MAT) program for opioid abuse. The PMHNP must check the prescription drug monitoring program (PMP) website at least every 90 days for patients who receive these prescriptions. Which of the following best describes the purpose of the PMP?

It is a program designed to monitor the opioid prescription habits of prescribers, to ensure they are not running "pill mills."

It is a program that allows prescribers to verify the controlled substance prescriptions associated with their DEA registration numbers to identify potential fraud, correct errors, and identify trends.

It is a program designed to monitor the prescribing habits of nurse practitioners and physician assistants only.

It is a program designed to monitor the opioid prescriptions of substance use disorder patients only.